Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Oncogene

• Publication date

  2009-01-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/onc.2008.374PMID 18836486
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification and characterization of ovarian cancer-initiating cells from primary human tumors.

  2008cited by this paper
• CD133: molecule of the moment

  2008cited by this paper
• Prostate cancer stem cells: a new target for therapy.

  2008cited by this paper
• Pluripotency Associated Genes Are Reactivated by Chromatin‐Modifying Agents in Neurosphere Cells

  2008influential reference
• Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics

  2008cited by this paper
• CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.

  2007influential reference
• Identification and expansion of human colon-cancer-initiating cells

  2007cited by this paper
• A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

  2007cited by this paper
• A stem cell–like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing

  2007cited by this paper
• Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens.

  2007cited by this paper
• Epigenetic stem cell signature in cancer

  2007cited by this paper
• The biology of cancer stem cells.

  2007cited by this paper
• Concise Review: Epigenetic Mechanisms Contribute to Pluripotency and Cell Lineage Determination of Embryonic Stem Cells

  2007cited by this paper
• Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential.

  2007cited by this paper
• CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity

  2007cited by this paper
• Spontaneous Transformation of Human Adult Nontumorigenic Stem Cells to Cancer Stem Cells Is Driven by Genomic Instability in a Human Model of Glioblastoma

  2007cited by this paper
• Epigenetic "bivalently marked" process of cancer stem cell-driven tumorigenesis.

  2007cited by this paper
• The epigenomics of cancer.

  2007cited by this paper
• Dissecting the locus heterogeneity of autism: significant linkage to chromosome 12q14

  2007cited by this paper
• Chromosome 5q deletion and epigenetic suppression of the gene encoding α-catenin (CTNNA1) in myeloid cell transformation

  2007cited by this paper
• Identification and characterization of tumorigenic liver cancer stem/progenitor cells.

  2007cited by this paper
• Detection of tumor stem cell markers in pancreatic carcinoma cell lines.

  2007cited by this paper
• Expression of CD133-1 and CD133-2 in ovarian cancer

  2007cited by this paper
• GATHER: a systems approach to interpreting genomic signatures

  2006cited by this paper
• Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness.

  2006influential reference
• Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

  2006cited by this paper
• NCBI GEO: mining tens of millions of expression profiles—database and tools update

  2006influential reference
• High throughput detection of M6P/IGF2R intronic hypermethylation and LOH in ovarian cancer

  2006cited by this paper
• Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines.

  2006cited by this paper
• Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer.

  2005cited by this paper
• Patterns of Gene Expression That Characterize Long-term Survival in Advanced Stage Serous Ovarian Cancers

  2005influential reference
• Isolation of neural stem cells from the postnatal cerebellum

  2005cited by this paper
• Prospective identification of tumorigenic prostate cancer stem cells.

  2005influential reference
• ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma.

  2005cited by this paper
• Identification of human brain tumour initiating cells

  2004cited by this paper
• Alternative promoters regulate transcription of the gene that encodes stem cell surface protein AC133.

  2004influential reference
• [The expression and functional characteristics of AC133 antigen in cord blood hematopoietic cells].

  2002cited by this paper
• The Human AC133 Hematopoietic Stem Cell Antigen Is also Expressed in Epithelial Cells and Targeted to Plasma Membrane Protrusions*

  2000influential reference
• AC133, a novel marker for human hematopoietic stem and progenitor cells.

  1997cited by this paper
• Transforming growth factor‐beta inhibits proliferation of human ovarian cancer cells obtained from ascites

  1994influential reference
• Unifocal origin of advanced human epithelial ovarian cancers.

  1992influential reference
• Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation.

  1992influential reference

• BNIP3L/BNIP3‐Mediated Mitophagy Contributes to the Maintenance of Ovarian Cancer Stem Cells

  2025cites this paper
• Decoding Pediatric Inherited Retinal Dystrophies: Bridging Genetic Complexity and Clinical Heterogeneity.

  2025cites this paper
• Inhibition of DNA polymerase eta‐mediated translesion DNA synthesis with small molecule sensitises ovarian cancer stem‐like cells to chemotherapy

  2025cites this paper
• Competing endogenous RNA networks in ovarian cancer: from bench to bedside

  2025cites this paper
• Homologous recombination deficiency: a reliable biomarker or a misleading indicator?

  2025cites this paper
• Determination of high-grade serous ovarian cancer stem cell-based subtypes and prognostic model and identification of highly expressed VSIG4 and STAB1 in macrophages

  2025cites this paper
• Death-ision: the link between cellular resilience and cancer resistance to treatments

  2025cites this paper
• Advances in ovarian tumor stem cells and therapy

  2024cites this paper
• Exploring the Potential of Natural Killer Cell-Based Immunotherapy in Targeting High-Grade Serous Ovarian Carcinomas

  2024cites this paper
• Emerging roles of prominin-1 (CD133) in the dynamics of plasma membrane architecture and cell signaling pathways in health and disease

  2024cites this paper
• Unveiling stem-like traits and chemoresistance mechanisms in ovarian cancer cells through the TGFβ1-PITX2A/B signaling axis.

  2024cites this paper
• Anabolic Steroids Activate the NF-κB Pathway in Porcine Ovarian Putative Stem Cells Independently of the ZIP-9 Receptor

  2024cites this paper
• Global research landscape and trends of cancer stem cells from 1997 to 2023: A bibliometric analysis

  2024cites this paper
• CD133-targeted afatinib nanomicelles for enhanced lung cancer theranostics.

  2024cites this paper
• Bisphenol A-induced oxidative stress increases the production of ovarian cancer stem cells in mice.

  2024cites this paper
• Application of single cell sequencing technology in ovarian cancer research (review)

  2024cites this paper
• Periostin facilitates ovarian cancer recurrence by enhancing cancer stemness

  2023cites this paper
• Understanding cancer stem cells and plasticity: Towards better therapeutics.

  2023cites this paper
• Suicide gene strategies applied in ovarian cancer studies

  2023cites this paper
• Defining the Role of Metastasis-Initiating Cells in Promoting Carcinogenesis in Ovarian Cancer

  2023cites this paper
• Stem cell properties of cancer cells in ascitic fluid of patients with ovarian cancer: a key to control over cancer progression

  2023cites this paper
• Predicting Prognosis and Platinum Resistance in Ovarian Cancer: Role of Immunohistochemistry Biomarkers

  2023cites this paper
• Profiling ovarian cancer tumor and microenvironment during disease progression for cell-based immunotherapy design

  2023cites this paper
• A putative role for ALDH inhibitors and chemoprevention of BRCA-mutation-driven tumors.

  2023cites this paper
• “DEPHENCE” system—a novel regimen of therapy that is urgently needed in the high-grade serous ovarian cancer—a focus on anti-cancer stem cell and anti-tumor microenvironment targeted therapies

  2023cites this paper
• Immunization with Embryonic Stem Cells/Induced Pluripotent Stem Cells Induces Effective Immunity against Ovarian Tumor-Initiating Cells in Mice

  2023cites this paper
• Applications of Innovation Technologies for Personalized Cancer Medicine: Stem Cells and Gene-Editing Tools.

  2023cites this paper
• Functional Roles of CD133: More than Stemness Associated Factor Regulated by the Microenvironment

  2023cites this paper
• Ovarian cancer stem cells: Critical roles in anti-tumor immunity

  2022cites this paper
• Identification, Culture and Targeting of Cancer Stem Cells

  2022cites this paper
• CD133 is an independent predictive and prognostic marker in metastatic breast cancer

  2022cites this paper
• Prostate Cancer Stem Cells: The Role of CD133

  2022cites this paper
• A Novel ALDH1A1 Inhibitor Blocks Platinum-Induced Senescence and Stemness in Ovarian Cancer

  2022influential citation
• Nanoplatform to Investigate Tumor-Initiating Cancer Stem Cells: Breaking the Diagnostic Barrier.

  2022cites this paper
• Aptamers as Smart Ligands for Targeted Drug Delivery in Cancer Therapy

  2022cites this paper
• Molecular mechanisms of platinum-based chemotherapy resistance in ovarian cancer

  2022cites this paper
• Current Approach to Cancer Stem Cells

  2022cites this paper
• Peritoneal dissemination of high-grade serous ovarian cancer: pivotal roles of chromosomal instability and epigenetic dynamics

  2022cites this paper
• Cancer Stem Cells in Ovarian Cancer—A Source of Tumor Success and a Challenging Target for Novel Therapies

  2022cites this paper
• Ovarian cancer stem cell biology and chemoresistance

  2021cites this paper
• Ovarian Cancer Stem Cells: Newer Horizons

  2021cites this paper
• Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents

  2021cites this paper
• Role of ROS in Cancer Stem Cells

  2021cites this paper
• Aberrant activation of Wnt/catenin signaling and overexpression of ABCG2 contributes to apoptosis down regulation and tumor progression of high grade ovarian cancer.

  2021cites this paper
• Anabolic Steroids-Driven Regulation of Porcine Ovarian Putative Stem Cells Favors the Onset of Their Neoplastic Transformation

  2021cites this paper
• Personalized Models of Heterogenous 3D Epithelial Tumor Microenvironments: Ovarian Cancer as a Model.

  2021cites this paper
• An Overview of Antioxidative Anticancer Therapies with Reference to the Cancer Stem Cells

  2021cites this paper
• Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancer

  2021cites this paper
• HDAC Inhibitors: Dissecting Mechanisms of Action to Counter Tumor Heterogeneity

  2021cites this paper
• Ovarian Cancer Stem Cells: Characterization and Role in Tumorigenesis.

  2021cites this paper
• The Hallmarks of Ovarian Cancer Stem Cells and Niches: Exploring Their Harmonious Interplay in Therapy Resistance.

  2021cites this paper
• Epigenetic Regulation of Claudin-1 in the Development of Ovarian Cancer Recurrence and Drug Resistance

  2021cites this paper
• Does GD2 synthase (GD2S) detect cancer stem cells in blood samples of breast carcinomas?

  2021cites this paper
• ZEB2 facilitates peritoneal metastasis by regulating the invasiveness and tumorigenesis of cancer stem-like cells in high-grade serous ovarian cancers

  2021cites this paper
• Magnetic nanomedicine for CD133-expressing cancer therapy using locoregional hyperthermia combined with chemotherapy.

  2020cites this paper
• Epigenetic regulation of cancer stem cell formation and maintenance

  2020cites this paper
• EZH2-Mediated Downregulation of the Tumor Suppressor DAB2IP Maintains Ovarian Cancer Stem Cells

  2020cites this paper
• The oncogenic potential of NANOG: An important cancer induction mediator

  2020cites this paper
• Cancer Stem Cells: New Horizons in Cancer Therapies

  2020cites this paper
• Metformin’s Modulatory Effects on miRNAs Function in Cancer Stem Cells—A Systematic Review

  2020influential citation
• Napabucasin overcomes cisplatin resistance in ovarian germ cell tumor-derived cell line by inhibiting cancer stemness

  2020cites this paper
• Stem Cells in Ovarian Cancer and Potential Therapies

  2020cites this paper
• Carcinoma-Associated Mesenchymal Stem Cells Promote Chemoresistance in Ovarian Cancer Stem Cells via PDGF Signaling

  2020cites this paper
• Ovarian cancer stem cells: ready for prime time?

  2020cites this paper
• Targeting Cancer Stem Cells by Genetically Engineered Chimeric Antigen Receptor T Cells

  2020cites this paper
• Genome-Wide DNA Methylation Enhances Stemness in the Mechanical Selection of Tumor-Repopulating Cells

  2020cites this paper
• Targeting cancer stem cells by melatonin: Effective therapy for cancer treatment.

  2020cites this paper
• Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer

  2020cites this paper
• The Capacity of High-Grade Serous Ovarian Cancer Cells to Form Multicellular Structures Spontaneously along Disease Progression Correlates with Their Orthotopic Tumorigenicity in Immunosuppressed Mice

  2020cites this paper
• The expression levels and clinical significance of MFG-E8 and CD133 in epithelial ovarian cancer

  2020cites this paper
• Controversies in Isolation and Characterization of Cancer Stem Cells

  2020cites this paper
• An evolving paradigm of cancer stem cell hierarchies: therapeutic implications

  2020cites this paper
• Characteristics of CD133-Sustained Chemoresistant Cancer Stem-Like Cells in Human Ovarian Carcinoma

  2020cites this paper
• The Effect of Plant-Derived Compounds in Targeting Cancer Stem Cells

  2019cites this paper
• Colon cancer stemness as a reversible epigenetic state: Implications for anticancer therapies

  2019cites this paper
• The Use of Multi-Targeting Natural Products for the Treatment of Cancer

  2019cites this paper
• Presence and role of stem cells in ovarian cancer

  2019cites this paper
• Inhibition of miR-328-3p Impairs Cancer Stem Cell Function and Prevents Metastasis in Ovarian Cancer.

  2019cites this paper
• Relevance of Circulating Tumor Cells , Extracellular Nucleic Acids and Exosomes in 1 Breast Cancer 2 3

  2019cites this paper
• Notch 3 Targeting : A Novel Weapon against Ovarian Cancer Stem Cells

  2019cites this paper
• The Role of Intra-Tumoral Heterogeneity and Its Clinical Relevance in Epithelial Ovarian Cancer Recurrence and Metastasis

  2019cites this paper
• The Role of Cancer Stem Cells and Mechanical Forces in Ovarian Cancer Metastasis

  2019cites this paper
• The MEK1/2 Pathway as a Therapeutic Target in High-Grade Serous Ovarian Carcinoma

  2019cites this paper
• MDA-9/Syntenin (SDCBP) Is a Critical Regulator of Chemoresistance, Survival and Stemness in Prostate Cancer Stem Cells

  2019cites this paper
• A Novel ALDH1A1 Inhibitor Targets Cells with Stem Cell Characteristics in Ovarian Cancer

  2019cites this paper
• Magnetite-based nanomedicine for cancer diagnosis and therapy using loco-regional hyperthermia combined with chemotherapy

  2019cites this paper
• Ovarian cancer stem cells: What progress have we made?

  2019cites this paper
• Ovarian Cancer Stemness: Biological and Clinical Implications for Metastasis and Chemotherapy Resistance

  2019cites this paper
• Ovarian Cancer Stem Cells: Role in Metastasis and Opportunity for Therapeutic Targeting

  2019cites this paper
• Ovarian cancer stem cells and their role in drug resistance.

  2019cites this paper
• Genomics, Proteomics, and Metabolomics of Cancer Stem Cells (CSCs)

  2019cites this paper
• Key actors in cancer therapy: epigenetic modifiers

  2019cites this paper
• Relationship between ovarian cancer stem cells, epithelial mesenchymal transition and tumour recurrence

  2019influential citation
• Notch3 Targeting: A Novel Weapon against Ovarian Cancer Stem Cells

  2019cites this paper
• The expression of CD markers in solid tumors: Significance in metastasis and prognostic value.

  2018cites this paper
• The enhanced delivery of salinomycin to CD133+ ovarian cancer stem cells through CD133 antibody conjugation with poly(lactic-co-glycolic acid)-poly(ethylene glycol) nanoparticles.

  2018cites this paper
• Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism

  2018cites this paper
• Stem Cells for the Treatment of Ovarian Cancer

  2018cites this paper
• DDB2 represses ovarian cancer cell dedifferentiation by suppressing ALDH1A1

  2018cites this paper
• Aggressive serous epithelial ovarian cancer is potentially propagated by EpCAM+CD45+ phenotype

  2018cites this paper